An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients

Infection Control and Hospital Epidemiology

Volumn 29, Issue 9, 2008, Pages 866-870

  Adler, Amanda L ^c   Casper, Corey ^b,d,e   Boeckh, Michael ^b,d   Heath, Joan ^c   Zerr, Danielle M ^a,c,f  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e Infection Control Program   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; IMMUNOGLOBULIN; THYMOCYTE ANTIBODY; VALACICLOVIR;

ACUTE DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ANAMNESIS; ARTICLE; CANCER PATIENT; CHICKENPOX; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; ENVIRONMENTAL EXPOSURE; EPIDEMIC; FAMILY; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEALTH CENTER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; MACULOPAPULAR RASH; MALE; MEDULLOBLASTOMA; OUTPATIENT DEPARTMENT; PAPULOVESICULAR RASH; PROPHYLAXIS; RHABDOMYOSARCOMA; SCHOOL; SEROLOGY; STAFF; TERTIARY HEALTH CARE; VACCINATION; VARICELLA ZOSTER VIRUS; WILD TYPE;

ADULT; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FAMILY; FEMALE; HERPESVIRUS 3, HUMAN; HOSPITALS, PEDIATRIC; HOUSING; HUMANS; IMMUNOCOMPROMISED HOST; INFECTION CONTROL; MALE; NEOPLASMS; TIME FACTORS; VACCINATION;

EID: 51849086440     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/590358     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 10th ed. Washington, DC: Public Health Foundation; 2008.
2. American Academy of Pediatrics. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove, IL: American Academy of Pediatrics; 2006.
3. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996;45(RR-11):1-36.
4. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002;347:1909-1915.
5. Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 2004;113:455-459.
6. Lopez AS, Guris D, Zimmerman L, et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics 2006;117:e1070-1077.
7. Council of State and Territorial Epidemiologists (CSTE). 1999 Position Statements. CSTE Annual Meeting; 1999; Madison, WI. Position Statements ID-9.
8. Weinstock DM, Boeckh M, Boulad F, et al. Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues. Infect Cont Hosp Epidemiol 2004;25:603-608.
9. Bernstein HH, Rothstein EP, Watson BM, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics 1993;92:833-837.
10. Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases. JAMA 2004;292:704-708.
11. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56(RR-4)1-40.
12. Lopez AS, Burnett-Hartman A, Nambiar R, et al. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 2008;197:646-653.
13. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchmann SD. Guideline for infection control in healthcare personnel. Infect Control Hosp Epidemiol 1998;19:407-463.
14. Ljungman P, Lonnqvist B, Gahrton G, Ringden O, Sundqvist VA, Wahren B. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis 1986;153:840-847.